26
20
Brain Tumor Reports

Volume 15 Number 8
August 2015

Home > Publications > Brain Tumor Reports > Volume 15, Year 2015 > Number 8, August°


CONTENTS



BRAIN TUMORS
DIFFUSE ASTROCYTOMA
GLIOBLASTOMA
GLIOMAS
MALIGNANT LYMPHOMA
METASTATIC TUMORS
OLIGODENDROGLIOMA





BRAIN TUMORS



Kilburn LB, Kocak M, Decker RL, Wetmore C, Chintagumpala M, Su J, Goldman S, Banerjee A, Gilbertson R, Fouladi M, Kun L, Boyett JM, Blaney SM.
A phase 1 and pharmacokinetic study of enzastaurin in pediatric patients with refractory primary central nervous system tumors: a pediatric brain tumor consortium study.
Neuro Oncol. 2015 Feb;17(2):303-11. doi: 10.1093/neuonc/nou114. Epub 2014 Nov 27.
Source | Abstract | Full text | Similar articles





DIFFUSE ASTROCYTOMA



Baek HJ, Kim SM, Chung SY, Park MS.
Hemorrhagic Recurrence in Diffuse Astrocytoma without Malignant Transformation.
Brain Tumor Res Treat. 2014 Oct;2(2):119-23. doi: 10.14791/btrt.2014.2.2.119. Epub 2014 Oct 31.
Source | Abstract | Full text | Similar articles





GLIOBLASTOMA



Franceschi E, Ermani M, Bartolini S, Bartolotti M, Poggi R, Tallini G, Marucci G, Fioravanti A, Tosoni A, Agati R, Bacci A, Pozzati E, Morandi L, Balestrini D, Ghimenton C, Crisi G, Brandes AA.
Post progression survival in glioblastoma: where are we?
J Neurooncol. 2014 Nov 1. doi:10.1007/s11060-014-1651-7. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Hassler MR, Sax C, Flechl B, Ackerl M, Preusser M, Hainfellner JA, Woehrer A, Dieckmann KU, Rössler K, Prayer D, Marosi C.
Thalidomide as Palliative Treatment in Patients with Advanced Secondary Glioblastoma.
Oncology. 2014 Nov 21;88(3):173-179. https://doi.org/10.1159/000368903. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Hunn MK, Bauer E, Wood CE, Gasser O, Dzhelali M, Ancelet LR, Mester B, Sharples KJ, Findlay MP, Hamilton DA, Hermans IF
Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme.
J Neurooncol. 2014 Oct 31. doi:10.1007/s11060-014-1635-7. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Kim W, Yoo H, Shin SH, Gwak HS, Lee SH.
Extraneural Metastases of Glioblastoma without Simultaneous Central Nervous System Recurrence.
Brain Tumor Res Treat. 2014 Oct;2(2):124-7. doi: 10.14791/btrt.2014.2.2.124. Epub 2014 Oct 31.
Source | Abstract | Full text | Similar articles




Nguyen D, Rwigema JC, Yu VY, Kaprealian T, Kupelian P, Selch M, Lee P, Low DA, Sheng K.
Feasibility of extreme dose escalation for glioblastoma multiforme using 4π radiotherapy.
Radiat Oncol. 2014 Nov 7;9(1):239. [Epub ahead of print]
Source | Abstract | Full text | Similar articles




Omar AI.
Tumor treating field therapy in combination with bevacizumab for the treatment of recurrent glioblastoma.
J Vis Exp. 2014 Oct 27;(92):e51638. doi: 10.3791/51638.
Source | Abstract | Full text | Similar articles




Piccirillo SG, Spiteri I, Sottoriva A, Touloumis A, Ber S, Price SJ, Heywood R, Francis NJ, Howarth KD, Collins VP, Venkitaraman AR, Curtis C, Marioni JC, Tavaré S, Watts C.
Contributions to drug resistance in glioblastoma derived from malignant cells in the sub-ependymal zone.
Cancer Res. 2015 Jan 1;75(1):194-202. doi: 10.1158/0008-5472.CAN-13-3131. Epub 2014 Nov 18.
Source | Abstract | Full text | Similar articles




Schiff D, Kesari S, de Groot J, Mikkelsen T, Drappatz J, Coyle T, Fichtel L, Silver B, Walters I, Reardon D.
Phase 2 study of CT-322, a targeted biologic inhibitor of VEGFR-2 based on a domain of human fibronectin, in recurrent glioblastoma.
Invest New Drugs. 2015 Feb;33(1):247-53. doi: 10.1007/s10637-014-0186-2. Epub 2014 Nov 13.
Source | Abstract | Full text | Similar articles




Taylor JW, Dietrich J, Gerstner ER, Norden AD, Rinne ML, Cahill DP, Stemmer-Rachamimov A, Wen PY, Betensky RA, Giorgio DH, Snodgrass K, Randall AE, Batchelor TT, Chi AS.
Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma.
J Neurooncol. 2014 Nov 20. doi:10.1007/s11060-014-1667-z. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





GLIOMAS



Johnson BE, Mazor T, Hong C, Barnes M, Aihara K, McLean CY, Fouse SD, Yamamoto S, Ueda H, Tatsuno K, Asthana S, Jalbert LE, Nelson SJ, Bollen AW, Gustafson WC, Charron E, Weiss WA, Smirnov IV, Song JS, Olshen AB, Cha S, Zhao Y, Moore RA, Mungall AJ, Jones SJ, Hirst M, Marra MA, Saito N, Aburatani H, Mukasa A, Berger MS, Chang SM, Taylor BS, Costello JF.
Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma.
Science. 2014 Jan 10;343(6167):189-93. doi: 10.1126/science.1239947. Epub 2013 Dec 12.
Source | Abstract | Full text | Similar articles




Zhang RR, Pointer KB, Kuo JS, Dempsey RJ.
Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma.
Neurosurgery. 2014 Dec;75(6):N9-10. doi: 10.1227/NEU.0000000000000580.
Source | Abstract | Full text | Similar articles




HIGH-GRADE GLIOMAS


Müller K, Henke G, Compter I, von Bueren AO, Friedrich C, Janssens G, Kramm CM, Hundsberger T, Paulsen F, Kortmann RD, Zwiener I, Baumert BG.
External validation of a prognostic model estimating the survival of patients with recurrent high-grade gliomas after reirradiation.
Pract Radiat Oncol. 2014 Nov 18. pii: S1879-8500(14)00299-9. doi: 10.1016/j.prro.2014.10.001. [Epub ahead of print]
Source | Abstract | Full text | Similar articles





MALIGNANT LYMPHOMA



Pentsova E, Deangelis LM, Omuro A.
Methotrexate re-challenge for recurrent primary central nervous system lymphoma.
J Neurooncol. 2014 Mar;117(1):161-5. doi: 10.1007/s11060-014-1370-0. Epub 2014 Jan 31.
Source | Abstract | Full text | Similar articles





METASTATIC TUMORS



Dardis C, Milton K, Ashby L, Shapiro W.
Leptomeningeal metastases in high-grade adult glioma: development, diagnosis, management, and outcomes in a series of 34 patients.
Front Neurol. 2014 Nov 3;5:220. doi: 10.3389/fneur.2014.00220. eCollection 2014.
Source | Abstract | Full text | Similar articles